Rankings
▼
Calendar
BVS
Bioventus Inc.
$593M
Q4 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$130M
+32.3% YoY
Gross Profit
$88M
67.3% margin
Operating Income
-$3M
-2.4% margin
Net Income
-$364,000
-0.3% margin
EPS (Diluted)
$-0.01
QoQ Revenue Growth
+19.8%
Cash Flow
Operating Cash Flow
$13M
Free Cash Flow
$10M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$692M
Stockholders' Equity
$459M
Cash & Equivalents
$44M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$130M
$99M
+32.3%
Gross Profit
$88M
$73M
+19.5%
Operating Income
-$3M
$6M
-153.3%
Net Income
-$364,000
$3M
-113.1%
Revenue Segments
Restorative Therapies
$37M
100%
Geographic Segments
UNITED STATES
$115M
88%
Non-US
$15M
12%
← FY 2021
All Quarters
Q1 2022 →
BVS Q4 2021 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena